SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 496.60
0.00%
(0.00) 1D
Nov 9, 5:29:34 PM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Mkt. cap
177.60B
Avg. vol.
361.32K
Volume
0.00
P/E ratio
26.38
52-wk high
SEK 507.00
52-wk low
SEK 314.40
EPS
SEK 18.83
Shares outstanding
357.64M
No. of employees
2K
Mkt. cap
177.60B
Avg. vol.
361.32K
Volume
0.00
P/E ratio
26.38
52-wk high
SEK 507.00
52-wk low
SEK 314.40
EPS
SEK 18.83
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)
CEOGuido Oelkers
Employees2.21K
Founded1939
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitesobi.com